October 17, 2016

CLOSURES
GYNECOLOGIC
GOG-0215: Termination effective July 16, 2016; version date: February 10, 2011

AMENDMENTS AND UPDATES
BRAIN
RTOG 1122: Amendment 11, version date: October 3, 2016

RTOG 1205: Amendment 8, version date: October 3, 2016; also available on the CTSU website

BREAST
RTOG 1119: Amendments 5-7, version dates: July 22, 2016; September 7, 2016; October 10, 2016

GYNECOLOGIC
GOG-0086P: Amendment 14; version date: December 18, 2014 and Amendment 15; version date: October 3, 2016

GOG-9923: Amendment 19; version date: October 3, 2016

GOG-9927: Amendment 11; version date: October 3, 2016

OTHER PROTOCOL NOTICES
The VTOC Webinar Training Series schedule and registration is available for NRG Oncology Research Associates working on RTOG 0924, RTOG 0920, NRG-HN001, NRG-HN002, and NRG-CC003. Space is limited so register now and reserve your seat. The next webinar training is scheduled for October 19, 2016.

VisionTree FAQs for Research Associates and sites participating in the above mentioned trials can be found here and on the study-specific page on the CTSU website.

DRUG SAFETY UPDATES AND INVESTIGATOR BROCHURE NOTICES
Safety updates have been issued for GOG legacy studies. For details, please see the GOG Weekly Mailing page.

Safety updates have been issued for NSABP legacy studies. For details, please see the NSABP E-mail Distributions page and the CTSU website.

Safety updates have been issued for RTOG legacy studies. For details, please see the RTOG General Broadcast page.

Safety updates have been issued for the following NRG Oncology studies:
Ipilimumab: NRG-GY003, NRG-BN002

For NRG-GY003 safety reports, please see the protocol page on the NRG Oncology website for details.
For NRG-BN002 safety reports, please see the RTOG General Broadcast page for details.

An Investigator’s Brochure notice has been issued for the following NRG studies:
Olaparib (NRG-GY004 and NRG-GY005)

The current version of the Investigator Brochure Documents (IB-Summary of Changes) for Division of Cancer Treatment and Diagnosis (DCTD), National Cancer Institute (NCI)-sponsored trials is available for access via the Cancer Therapy Evaluation Program (CTEP) Online Agent Order Processing (OAOP) website:
https://eapps-ctep.nci.nih.gov/OAOP/pages/login.jsp
Log-in using your Identity and Access Management (IAM) username and password credentials and provide the requested information to access the document.

Catching Up with the Cancer Moonshot
WebMD spoke to NRG Oncology Co-chair, Walter Curran, MD. Read the interview here.

Want to be highlighted in the next NRG Oncology Newsletter for a recent accomplishment in cancer research?
If you were recently recognized or have won an award for your contributions in the field of cancer research, our Communications Committee would like to feature you in the “In the News” section of our upcoming NRG Oncology Newsletter. Please email info@nrgoncology.org and put “In the News” in the subject line. All submissions are due by November 18, 2016.

NRG Oncology is pleased to report the scientific articles and abstracts that have appeared or have been presented during the previous week. This publications report includes links, when available, to the article, PubMed abstract, or association abstract.

JOURNAL ARTICLES

Swisher SG, Moughan J, Komaki RU, Ajani JA, Wu TT, Hofstetter WL, Konski AA, Willett CG. Final Results of NRG Oncology RTOG 0246: An Organ Preserving Selective Resection Strategy in Esophageal Cancer Patients Treated with Definitive Chemoradiation. J Thorac Oncol. 2016 Oct 8. pii: S1556-0864(16)31141-8. doi: 10.1016/j.jtho.2016.10.002. PubMed PMID: 27729298. Read more

Cooper JS, Fortpied C, Gregoire V, Le QT, Pajak TF, Zhang QE, Bernier J. The role of postoperative chemoradiation for oropharynx carcinoma: A critical appraisal revisited. Cancer. 2016 Oct 11. doi: 10.1002/cncr.30266. PubMed PMID: 27727449. Read More

Wapnir IL, Gelber S, Anderson SJ, Mamounas EP, Robidoux A, Martín M, Nortier JW, Geyer CE Jr, Paterson AH, Láng I, Price KN, Coates AS, Gelber RD, Rastogi P, Regan MM, Wolmark N, Aebi S; CALOR trial investigators. Poor Prognosis after Second Locoregional Recurrences in the CALOR Trial. Ann Surg Oncol. 2016 Sep 23. [Epub ahead of print] PubMed PMID: 27663567. Read more

PUBLICATIONS REMINDERS
Please note the following upcoming meeting and abstract submission deadline dates.

Upcoming Meetings
Cochrane Colloquium; Oct 23-27, 2016; Seoul, South Korea

International Gynecologic Cancer Society (IGCS); Oct 29-31, 2016; Lisbon, Portugal

International Society for Quality of Life Research (ISOQOL); Oct 19-22, 2016; Copenhagen, Denmark

Society for Neuro-Oncology (SNO); Nov 17-20, 2016; Scottsdale, AZ

Upcoming abstract submission deadlines
American Association of Medical Dosimetrists (AAMD); Jun 10-15, 2017; Indianapolis, IN; meeting abstracts submission deadline Oct 31, 2016; deadline for posters Mar15, 2017

American Association of Neurological Surgeons (AANS); Apr 22-26, 2017; Los Angeles, CA; meeting abstracts submission deadline Oct 25, 2016

American Society of Breast Surgeons (ASBS); Apr 26-27, 2017; Las Vegas, NV; due to publications committee Oct 25, 2016; meeting abstracts submission deadline Nov 8, 2016

American Head & Neck Society (AHNS); Apr 26-27, 2017; San Diego, CA; due to publications committee Oct 26, 2016; meeting abstracts submission deadline Nov 9, 2016

American Society of Clinical Oncology (ASCO) GU; Feb 16-18, 2017; Orlando, FL; meeting abstracts submission deadline Oct 25, 2016

Inaugural Meeting ASCO/Society for Immunotherapy of Cancer (SITC); Feb 23-25, 2017; Orlando, FL; meeting abstracts submission deadline Oct 18, 2016

European Society for Radiotherapy and Oncology (ESTRO); May 5-9, 2017; Vienna, Austria; meeting abstracts submission deadline Oct 24, 2016

Society of Gynecologic Oncology (SGO); Mar 12-15, 2017; National Harbor, MD; meeting abstracts submission deadline Oct 31, 2016 Global session; Dec 5-Jan 8, 2017 LBA

NRG Oncology is proud to be an active participant of #CancerMoonShot.

View this email in your browser
You are receiving this email because of your relationship with NRG Oncology. Please reconfirm your interest in receiving emails from us. If you do not wish to receive any more emails, you can unsubscribe here.

Four Penn Center 1600 JFK Blvd. Suite1020 , Philadelphia, PA, 19103


Update Profile/Email Address